1. Home
  2. NSP vs CRSP Comparison

NSP vs CRSP Comparison

Compare NSP & CRSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NSP
  • CRSP
  • Stock Information
  • Founded
  • NSP 1986
  • CRSP 2013
  • Country
  • NSP United States
  • CRSP Switzerland
  • Employees
  • NSP N/A
  • CRSP N/A
  • Industry
  • NSP Professional Services
  • CRSP Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • NSP Consumer Discretionary
  • CRSP Health Care
  • Exchange
  • NSP Nasdaq
  • CRSP Nasdaq
  • Market Cap
  • NSP 2.9B
  • CRSP 3.4B
  • IPO Year
  • NSP 1997
  • CRSP 2016
  • Fundamental
  • Price
  • NSP $76.76
  • CRSP $40.53
  • Analyst Decision
  • NSP Hold
  • CRSP Buy
  • Analyst Count
  • NSP 4
  • CRSP 19
  • Target Price
  • NSP $95.67
  • CRSP $77.13
  • AVG Volume (30 Days)
  • NSP 391.8K
  • CRSP 1.8M
  • Earning Date
  • NSP 02-06-2025
  • CRSP 02-19-2025
  • Dividend Yield
  • NSP 3.12%
  • CRSP N/A
  • EPS Growth
  • NSP N/A
  • CRSP N/A
  • EPS
  • NSP 3.16
  • CRSP N/A
  • Revenue
  • NSP $6,547,871,000.00
  • CRSP $202,829,000.00
  • Revenue This Year
  • NSP $2.24
  • CRSP N/A
  • Revenue Next Year
  • NSP $5.31
  • CRSP $724.16
  • P/E Ratio
  • NSP $24.33
  • CRSP N/A
  • Revenue Growth
  • NSP 2.38
  • CRSP 19.31
  • 52 Week Low
  • NSP $71.69
  • CRSP $36.52
  • 52 Week High
  • NSP $117.48
  • CRSP $91.10
  • Technical
  • Relative Strength Index (RSI)
  • NSP 46.90
  • CRSP 44.09
  • Support Level
  • NSP $73.60
  • CRSP $36.52
  • Resistance Level
  • NSP $79.38
  • CRSP $40.99
  • Average True Range (ATR)
  • NSP 2.54
  • CRSP 1.78
  • MACD
  • NSP 0.18
  • CRSP 0.23
  • Stochastic Oscillator
  • NSP 47.12
  • CRSP 51.68

About NSP Insperity Inc.

Insperity Inc is a company that provides a wide range of human resources and business solutions designed to help businesses improve their performance. Small and midsize enterprises are the company's primary target customers. Majority of the company's products are offered through the company's Workforce Optimization and Workforce Synchronization solutions, which comprise various human resource functions, such as payroll and employment administration, employee benefits and compensation, government compliance, performance management, training and development services, and human capital management. The company generates all of its revenue in the United States.

About CRSP CRISPR Therapeutics AG

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.

Share on Social Networks: